Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.20
1.81%
After-hours: Aug 15, 2025, 07:54 PM EDT

Coya Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
38.34M 32.63M 5.93M 4.34M
Short-Term Investments
38.3B n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 1.12M 87.18K
Receivables
730.58K 7.5M n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
-38.3B n/a n/a n/a
Total Current Assets
44.31M 41.2M 7.18M 4.58M
Property-Plant & Equipment
38.59K 65.95K 93.31K 120.67K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
38.59K 65.95K 1.21M 207.85K
Total Assets
44.35M 41.26M 8.4M 4.79M
Account Payables
1.59M 1.16M 1.82M 857.57K
Deferred Revenue
848.29K 923.11K n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
255.64K n/a n/a n/a
Total Current Liabilities
3.82M 5.05M 3.82M 1.15M
Long-Term Debt
n/a n/a 12.97M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
945.45K 574.68K 12.97M 857.57K
Total Liabilities
4.77M 5.63M 16.79M 1.15M
Total Debt
n/a n/a 12.97M n/a
Common Stock
1.67K 1.44K 259.00 259.00
Retained Earnings
-40.74B -25.86M -17.87M -5.62M
Comprehensive Income
n/a -11.25K n/a n/a
Shareholders Equity
39.58M 35.64M -8.39M 3.64M
Total Investments
38.3B 11.25K n/a n/a